To: Bruce A. Brotnov who wrote (5940 ) 4/19/2002 2:25:12 PM From: Dave Gore Read Replies (1) | Respond to of 16631 Bruce, MRY (up 10%) is another breakout and solid fundamental pick; same niche as HQNT (i.e medical sector); could go a fair amount higher, based on PE alone and guidance. PE - 12.5 on trailing earnings. from the recent pr: James Binch, chairman and CEO of Memry said, "For the four quarters of the calendar year 2001, we reported earnings per share of $0.20 and revenue of $33,126,000, a gain of 14.4% over the $28,956,000 in revenue reported in the four quarters of calendar year 2000. This underscores the progress we are making in growing revenue, building and diversifying our customer base and controlling costs as well as the benefit we gained from spinning off our European operations. "We continue to see excellent demand for our shape memory materials in the healthcare area. This is highlighted by the growth in sales during the quarter of components for medical stents and for superelastic tube used in neurological, orthopaedic and embolic devices. We are also benefiting from continuing improvements in the operating efficiency of our West Coast operations and our new facility in Bethel. The outlook for the second half of our fiscal year is encouraging. Although the third fiscal quarter, which ends March 31, 2002 will most likely show a decrease in revenue and earnings compared with the strong third fiscal quarter last year, the outlook for the fourth fiscal quarter that ends June 30, 2002 and therefore the overall outlook for the second half of the current fiscal year is very promising. The current business momentum suggests that we are on track for reporting all time records for fiscal year 2002."